Compare SLP & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLP | BGH |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.7M | 279.7M |
| IPO Year | 1996 | 2011 |
| Metric | SLP | BGH |
|---|---|---|
| Price | $18.16 | $13.93 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $24.00 | N/A |
| AVG Volume (30 Days) | ★ 443.7K | 85.8K |
| Earning Date | 04-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $59,577,000.00 | N/A |
| Revenue This Year | $3.80 | N/A |
| Revenue Next Year | $5.90 | N/A |
| P/E Ratio | $69.81 | ★ N/A |
| Revenue Growth | ★ 10.52 | N/A |
| 52 Week Low | $11.09 | $13.19 |
| 52 Week High | $21.01 | $16.90 |
| Indicator | SLP | BGH |
|---|---|---|
| Relative Strength Index (RSI) | 66.94 | 46.94 |
| Support Level | $17.74 | $13.82 |
| Resistance Level | $19.29 | $13.96 |
| Average True Range (ATR) | 0.59 | 0.15 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 87.63 | 40.09 |
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation. The Fund seeks capital appreciation as a secondary investment objective when consistent with its primary investment objective. Under normal market conditions, the Fund will invest at least 80% of its Managed Assets in bonds, loans and other income-producing instruments that are, at the time of purchase, rated below investment grade.